Abstract
Monocyte chemoattractant protein-1 (MCP-1) is involved in the pathogenesis of chronic kidney diseases (CKD). MCP-1 2518 A>G gene polymorphism is associated with MCP-1 status. We performed a meta-analysis to assess the association between MCP-1 2518 A>G gene polymorphism and CKD risk. The eligible studies regarding the relationship between MCP-1 2518 A>G gene polymorphism and CKD risk were searched through electronic databases. The pooled odds ratios (ORs) and its 95% confidence intervals (CIs) were calculated by using a fixed-effects model, or in the presence of heterogeneity, a random-effects model. A total of 2415 cases and 2011 controls were recruited in our investigation. A allele/GG genotype was not associated with CKD risk in overall populations, Asians, Caucasians, and Africans. AA/AG genotype was not associated with the risk of CKD in overall populations, Asians, Caucasians, and Africans. AA genotype was associated with a lower risk of CKD in Caucasians (OR 0.816, 95% CI 0.703–0.947). AG genotype was associated with a higher risk of CKD in Caucasians (OR 1.230, 95% CI 1.042–1.452). There was no marked publication bias. In conclusion, AA genotype may be a protective factor against CKD susceptibility in Caucasians. AG genotype may be a risk factor for CKD risk in Caucasians. However, more studies are needed in the future.
Similar content being viewed by others
References
Yaseen A, Tresa V, Lanewala AA, Hashmi S, Ali I, Khatri S et al (2017) Acute kidney injury in idiopathic nephrotic syndrome of childhood is a major risk factor for the development of chronic kidney disease. Ren Fail 39:323–327
Visconti L, Benvenga S, Lacquaniti A, Cernaro V, Bruzzese A, Conti G et al (2016) Lipid disorders in patients with renal failure: role in cardiovascular events and progression of chronic kidney disease. J Clin Transl Endocrinol 6:8–14
Mahmoodnia L, Tamadon MR (2017) On the occasion of world kidney day 2017; obesity and its relationship with chronic kidney disease. J Nephropathol 6:105–109
Bergman S, Key BO, Kirk KA, Warnock DG, Rostant SG (1996) Kidney disease in the first- degree relatives of African-Americans with hypertensive end-stagerenal disease. Am J Kidney Dis 27:341–346
Akchurin OM, Kaskel F (2015) Update on inflammation in chronic kidney disease. Blood Purif 39:84–92
Tonelli M, Sacks F, Pfeffer M, Jhangri GS, Curhan G (2005) Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int 68:237–245
Jia T, Serbina NV, Brandl K, Zhong MX, Leiner IM, Charo IF et al (2008) Additive roles for MCP-1 and MCP-3 in CCR2-mediated recruitment of inflammatory monocytes during Listeria monocytogenes infection. J Immunol 180:6846–6853
Kolattukudy PE, Niu J (2012) Inflammation, endoplasmic reticulum stress, autophagy, and the monocyte chemoattractant protein-1/CCR2 pathway. Circ Res 110:174–189
Wu CC, Chen JS, Lu KC, Chen CC, Lin SH, Chu P, Sytwu HK, Lin YF (2010) Aberrant cytokines/chemokines production correlate with proteinuria in patients with overt diabetic nephropathy. Clin Chim Acta 411:700–704
Fukami A, Yamagishi S, Adachi H, Matsui T, Yoshikawa K, Ogata K, Kasahara A, Tsukagawa E, Yokoi K, Imaizumi T (2011) High white blood cell count and low estimated glomerular filtration rate are independently associated with serum level of monocyte chemoattractant protein-1 in a general population. Clin Cardiol 34:189–194
Gregg LP, Tio MC, Li X, Adams-Huet B, de Lemos JA, Hedayati SS (2018) Association of monocyte chemoattractant protein-1 with death and atherosclerotic events in chronic kidney disease. Am J Nephrol 47:395–405
Banba N, Nakamura T, Matsumura M, Kuroda H, Hattori Y, Kasai K (2000) Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy. Kidney Int 58:684–690
Hong SB, Jin SY, Park HJ, Jung JH, Sim WY (2006) Analysis of the monocyte chemoattractant protein 1 -2518 promoter polymorphism in Korean patients with alopecia areata. J Korean Med Sci 21:90–94
Zakharyan R, Boyajyan A, Arakelyan A, Melkumova M, Mrazek F, Petrek M (2012) Monocyte chemoattractant protein-1 in schizophrenia: -2518A/G genetic variant and protein levels in Armenian population. Cytokine 58:351–354
Joo KW, Hwang YH, Kim JH, Oh KH, Kim H, Shin HD et al (2007) MCP-1 and RANTES polymorphisms in Korean diabetic end-stage renal disease. J Korean Med Sci 22:611–615
Moon JY, Jeong L, Lee S, Jeong K, Lee T, Ihm CG et al (2007) Association of polymorphisms in monocyte chemoattractant protein-1 promoter with diabetic kidney failure in Korean patients with type 2 diabetes mellitus. J Korean Med Sci 22:810–814
Buraczynska M, Bednarek-Skublewska A, Buraczynska K, Ksiazek A (2008) Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for cardiovascular disease in hemodialyzed patients. Cytokine 44:361–365
Krichen H, Khazen D, Sfar I, Ben Abdallah T, Bardi R, Jendoubi-Ayed S et al (2011) Genetic polymorphisms of inflammatory molecules in Tunisian kidney transplantation. Transpl Proc 43:433-436
Ksiaa Cheikh Rouhou L, Gorgi YL, Skhiri HA, Aouadi H, Ayed SJ, Sfar I et al (2011) Chemokine and chemokine receptor gene polymorphism in Tunisian hemodialysis patients with HCV infection. Arab J Nephrol Transplant 4:117–124
Grzegorzewska AE, Pajzderski D, Sowińska A, Jagodziński PP (2014) Polymporphism of monocyte chemoattractant protein 1 (MCP1 -2518 A/G) and responsiveness to hepatitis B vaccination in hemodialysis patients. Pol Arch Med Wewn 124:10–18
Bagci B, Bagci G, Candan F, Ozdemir O, Sezgin I (2015) The protective effect of MCP-1 -2518 A>G promoter polymorphism in Turkish chronic renal failure patients requiring long-term hemodialysis. Int Urol Nephrol 47:551–556
Besbas N, Kalyoncu M, Cil O, Ozgul RK, Bakkaloglu A, Ozaltin F (2015) MCP1 2518 A/G polymorphism affects progression of childhood focal segmental glomerulosclerosis. Ren Fail 37:1435–1439
Raina P, Matharoo K, Bhanwer AJ (2015) Monocyte chemoattractant protein-1 (MCP-1)-2518 A> G polymorphism and susceptibility to type 2 diabetes (T2D) and end stage renal disease (ESRD) in the North-West Indian population of Punjab. Ann Hum Biol 42:276–282
Dounousi E, Koliousi E, Papagianni A, Ioannou K, Zikou X, Katopodis K et al (2012) Mononuclear leukocyte apoptosis and inflammatory markers in patients with chronic kidney disease. Am J Nephrol 36:531–536
Lin HY, Chang KT, Hung CC, Kuo CH, Hwang SJ, Chen HC et al (2014) Effects of the mTOR inhibitor rapamycin on monocyte-secreted chemokines. BMC Immunol 15:37
Moledina DG, Isguven S, McArthur E, Thiessen-Philbrook H, Garg AX, Shlipak M et al (2017) Plasma monocyte chemotactic protein-1 is associated with acute kidney injury and death after cardiac operations. Ann Thorac Surg 104:613–620
Rovin BH, Song H, Birmingham DJ, Hebert LA, Yu CY, Nagaraja HN (2005) Urine chemokines as biomarkers of human systemic lupus erythematosus activity. J Am Soc Nephrol 16:467–473
Keeney M, Waters H, Barcay K, Jiang X, Yao Z, Pajarinen J, Egashira K, Goodman SB, Yang F (2013) Mutant MCP-1 protein delivery from layer-by-layer coatings on orthopedic implants to modulate inflammatory response. Biomaterials 34:10287–10295
Fenoglio C, Galimberti D, Lovati C, Guidi I, Gatti A, Fogliarino S et al (2004) MCP-1 in Alzheimer’s disease patients: A-2518G polymorphism and serum levels. Neurobiol Aging 25:1169–1173
Namlı Kalem M, Akgun N, Kalem Z, Bakirarar B, Celik T (2017) Chemokine (C-C motif) ligand-2 (CCL2) and oxidative stress markers in recurrent pregnancy loss and repeated implantation failure. J Assist Reprod Genet 34:1501–1506
Zoja C, Corna D, Locatelli M, Rottoli D, Pezzotta A, Morigi M et al (2015) Effects of MCP-1 inhibition by bindarit therapy in a rat model of polycystic kidney disease. Nephron 129:52–61
Serwin NM, Wiśniewska M, Jesionowska A, Skwirczyńska E, Marcinowska Z, Dołęgowska B (2016) Serum levels of 12 renal function and injury markers in patients with glomerulonephritis. Pol Arch Med Wewn 126:483–493
Meijer E, Boertien WE, Nauta FL, Bakker SJ, van Oeveren W, Rook M et al (2010) Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis. Am J Kidney Dis 56:883–895
Tabara Y, Kohara K, Yamamoto Y, Igase M, Nakura J, Kondo I et al (2003) Polymorphism of the monocyte chemoattractant protein (MCP-1) gene is associated with the plasma level of MCP-1 but not with carotid intima-media thickness. Hypertens Res 26:677–683
Davis TM, Makepeace AE, Ellard S, Colclough K, Peters K, Hattersley A et al (2017) The prevalence of monogenic diabetes in Australia: the Fremantle Diabetes Study Phase II. Med J Aust 207:344–347
Yang P, Xiao Y, Luo X, Zhao Y, Zhao L, Wang Y et al (2017) Inflammatory stress promotes the development of obesity-related chronic kidney disease via CD36 in mice. J Lipid Res 58:1417–1427
Umare VD, Pradhan VD, Rajadhyaksha AG, Ghosh K, Nadkarni AH (2017) A functional SNP MCP-1 (-2518A/G) predispose to renal disorder in Indian Systemic Lupus Erythematosus patients. Cytokine 96:189–194
Su N, Li HY, Huang MF, Jiang ZP, Zhou TB (2015) Association of monocyte chemoattractant protein-1 2518G/A gene polymorphism with diabetic nephropathy risk. J Recept Signal Transduct Res 35:94–97
Piotrowski P, Lianeri M, Gasik R, Roszak A, Olesińska M, Jagodziński PP (2010) Monocyte chemoattractant protein-1 -2518 A/G single nucleotide polymorphism might be associated with renal disease and thrombocytopenia of SLE. J Biomed Biotechnol 2010:130265
Tesch GH (2008) MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. Am J Physiol Renal Physiol 294:F697–F701
Acknowledgements
This study was supported by Grant from the National Natural Science Foundation of China (Grant Number 81600578) and weak discipline construction of Shanghai health and family planning commission (Grant Number 2016ZB0102-03).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
There is no conflict of interest for all authors.
Rights and permissions
About this article
Cite this article
Mao, S., Wu, L. Association between MCP-1 2518 A>G gene polymorphism and chronic kidney disease. Int Urol Nephrol 50, 2245–2253 (2018). https://doi.org/10.1007/s11255-018-1955-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-018-1955-1